Correlation between large rearrangements and patient phenotypes in NF1 deletion syndrome: an update and review

被引：0
作者：
Laurence Pacot
Milind Girish
Samantha Knight
Gill Spurlock
Vinod Varghese
Manuela Ye
Nick Thomas
Eric Pasmant
Meena Upadhyaya
机构：
[1] Hôpital Cochin,Fédération de Génétique et Médecine Génomique
[2] DMU BioPhyGen,School of Clinical Medicine
[3] AP-HP,Division of Cancer and Genetics, Institute of Medical Genetics
[4] Centre-Université Paris Cité,undefined
[5] Institut Cochin,undefined
[6] Inserm U1016,undefined
[7] CNRS UMR8104,undefined
[8] Université Paris Cité,undefined
[9] CARPEM,undefined
[10] University of Cambridge,undefined
[11] Cardiff University,undefined
[12] Cardiff University,undefined
[13] All Wales Medical Genomics Service,undefined
来源：
BMC Medical Genomics | / 17卷
关键词：
Neurofibromatosis type 1; NF1; Deletion; CNV; Genotype-phenotype correlation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
About 5–10% of neurofibromatosis type 1 (NF1) patients exhibit large genomic germline deletions that remove the NF1 gene and its flanking regions. The most frequent NF1 large deletion is 1.4 Mb, resulting from homologous recombination between two low copy repeats. This “type-1” deletion is associated with a severe clinical phenotype in NF1 patients, with several phenotypic manifestations including learning disability, a much earlier development of cutaneous neurofibromas, an increased tumour risk, and cardiovascular malformations. NF1 adjacent co-deleted genes could act as modifier loci for the specific clinical manifestations observed in deleted NF1 patients. Furthermore, other genetic modifiers (such as CNVs) not located at the NF1 locus could also modulate the phenotype observed in patients with large deletions. In this study, we analysed 22 NF1 deletion patients by genome-wide array-CGH with the aim (1) to correlate deletion length to observed phenotypic features and their severity in NF1 deletion syndrome, and (2) to identify whether the deletion phenotype could also be modulated by copy number variations elsewhere in the genome. We then review the role of co-deleted genes in the 1.4 Mb interval of type-1 deletions, and their possible implication in the main clinical features observed in this high-risk group of NF1 patients.
引用
收藏
相关论文
共 368 条
[1]  
Pacot L(2021)Severe phenotype in patients with large deletions of NF1 Cancers (Basel) 13 2963-49
[2]  
Vidaud D(2021)Classification of NF1 microdeletions and its importance for establishing genotype/phenotype correlations in patients with NF1 microdeletions Hum Genet 140 1635-26
[3]  
Sabbagh A(2014)SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints Genome Biol 15 R80-73
[4]  
Laurendeau I(2014)Analysis of crossover breakpoints yields new insights into the nature of the gene conversion events associated with large NF1 deletions mediated by nonallelic homologous recombination Hum Mutat 35 215-83
[5]  
Briand-Suleau A(2010)Intrachromosomal mitotic nonallelic homologous recombination is the major molecular mechanism underlying type-2 NF1 deletions Hum Mutat 31 1163-9
[6]  
Coustier A(2012)Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3 NF1 deletions Hum Mutat 33 372-609
[7]  
Kehrer-Sawatzki H(2009)Detection and characterization of NF1 microdeletions by custom high resolution array CGH J Mol Diagn 11 524-66
[8]  
Cooper DN(2012)Identification of recurrent type-2 NF1 microdeletions reveals a mitotic nonallelic homologous recombination hotspot underlying a human genomic disorder Hum Mutat 33 1599-8
[9]  
Vogt J(2008)Characterization of a 7.6-Mb germline deletion encompassing the NF1 locus and about a hundred genes in an NF1 contiguous gene syndrome patient Eur J Hum Genet 16 1459-30
[10]  
Bengesser K(2022)Contribution of whole genome sequencing in the molecular diagnosis of mosaic partial deletion of the NF1 gene in neurofibromatosis type 1 Hum Genet 12 1639-1518
12345678910